Skip to main content

New Jersey Aims to Ensure That All Children Have Health Insurance


John Klein has led Teaneck, New Jersey-based Cambridge Therapeutics since founding the pharmaceutical products manufacturer nearly a decade ago. He and his company provide a range of customer-friendly medical packaging options designed to increase patient adherence to prescription regimens. In addition to his role with Cambridge Therapeutics, John Klein is a board member with Hackensack Meridian Health Hospitals and regularly studies emerging information in the healthcare field in his state.

In order to care for the most vulnerable of its citizens, the state of New Jersey oversees NJFamilyCare, a publicly funded insurance program that offers free or affordable health insurance for individuals of all ages. The program entitles policy holders to obtain visits to physicians, dentists, mental health professionals, and vision care specialists, as well as hospital services.

However, the research group New Jersey Policy Perspective noted that the number of children enrolled in NJFamilyCare has decreased over the past year. And a new study shows that there remain significant gaps in levels of health insurance coverage stemming from ethnic, geographic, and socioeconomic differences. Simply put, there are a large number of children in New Jersey - estimates put the number at close to 80,000 - who need subsidized health insurance, but whose families have not yet taken advantage of it.

New Jersey lawmakers have stated their goal of expanding this coverage. They plan to direct specialized outreach efforts to communities of color and to work to eliminate barriers to enrollment that may exist for immigrant families and other particularly vulnerable groups.
Labels:

Comments

Post a Comment

Popular posts from this blog

Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services. Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur. This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and r...
Post a Comment
Read more

Overview of the EPM Solution Chain

In 2011, John Klein founded Cambridge Therapeutics in Alpine, New Jersey, where he currently serves as chairman. Four years later, John Klein expanded his professional endeavors beyond Cambridge Therapeutics by founding Bilogix, LLC, an enterprise performance management (EPM) services provider also based in Alpine, NJ. The EPM solution chain consists of five key points that can be optimized to address the needs of specific industries and vendors. Strategy and metrics visualization is the first step in the EPM solution chain and involves a number of strategy maps and business activity monitoring processes, along with the scorecards and dashboards often associated with EPM support. Enterprise planning and budgeting, meanwhile, can be described as the strategic integration of budgeting and forecasting applications with tactical enterprise planning efforts. Financial modeling and analysis is another important part of the EPM solution chain and can be achieved through a range of proce...
Post a Comment
Read more